文献速递糖尿病

出生时预测1型糖尿病:脐带血代谢物与遗传风险评分的比较

Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

在挪威母亲、父亲与儿童队列中,对166例日后发生1型糖尿病的儿童和177例随机对照儿童检测脐带血中27种低分子量极性代谢物。所选代谢物与1型糖尿病均无显著关联,聚类分析亦无关联,代谢物预测AUC为0.49,而非HLA遗传风险评分AUC为0.56、HLA风险分组AUC为0.78。结论不支持脐带血中所选胆汁酸及其他小极性代谢物对1型糖尿病具有预测作用。

要点

  • 脐带血所选27种极性代谢物与日后1型糖尿病无显著关联。
  • 代谢物预测AUC为0.49,无预测价值;HLA风险分组AUC为0.78。
  • 非HLA遗传风险评分AUC为0.56,预测能力有限。

核心结论

  • 所选脐带血胆汁酸及其他小极性代谢物浓度对1型糖尿病发展无预测作用。

研究设计与样本

  • 挪威母亲、父亲与儿童队列中166例日后发生1型糖尿病儿童与177例随机对照儿童的病例对照研究。
  • 采用靶向UHPLC-QQQ-MS平台定量27种低分子量代谢物,包括氨基酸、小有机酸和胆汁酸。
  • 采用逻辑回归估计每标准差比值比(aOR)、ROC曲线下面积(AUC)和k-means聚类分析。
  • 与基于51个已确立非HLA单核苷酸多态性的遗传风险评分及4分类HLA风险分组进行比较。

主要发现

  • 最强关联为氨基己二酸(aOR=1.23;95%CI,0.97-1.55)、吲哚硫酸盐(aOR=1.15;95%CI,0.87-1.51)和色氨酸(aOR=0.84;95%CI,0.65-1.10),均不显著。
  • 其他代谢物aOR接近1.0,无一与1型糖尿病显著相关。
  • k-means聚类识别出6个聚类,均与1型糖尿病无关。
  • 交叉验证AUC显示代谢物无预测价值(AUC 0.49),非HLA遗传风险评分AUC为0.56,HLA风险分组AUC为0.78。

临床怎么用

  • 不支持将脐带血中所选胆汁酸及其他小极性代谢物用于1型糖尿病出生时风险预测。
  • HLA风险分组在该队列中预测能力较高(AUC 0.78),非HLA遗传风险评分预测能力有限(AUC 0.56)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Genetic markers are established as predictive of type 1 diabetes, but unknown early life environment is believed to be involved. Umbilical cord blood may reflect perinatal metabolism and exposures. We studied whether selected polar metabolites in cord blood contribute to prediction of type 1 diabetes. METHODS: Using a targeted UHPLC-QQQ-MS platform, we quantified 27 low-molecular-weight metabolites (including amino acids, small organic acids, and bile acids) in 166 children, who later developed type 1 diabetes, and 177 random control children in the Norwegian Mother, Father, and Child cohort. We analyzed the data using logistic regression (estimating odds ratios per SD [adjusted odds ratio (aOR)]), area under the receiver operating characteristic curve (AUC), and k-means clustering. Metabolites were compared to a genetic risk score based on 51 established non-HLA single-nucleotide polymorphisms, and a 4-category HLA risk group. RESULTS: The strongest associations for metabolites were aminoadipic acid (aOR = 1.23; 95% CI, 0.97-1.55), indoxyl sulfate (aOR = 1.15; 95% CI, 0.87-1.51), and tryptophan (aOR = 0.84; 95% CI, 0.65-1.10), with other aORs close to 1.0, and none significantly associated with type 1 diabetes. K-means clustering identified 6 clusters, none of which were associated with type 1 diabetes. Cross-validated AUC showed no predictive value of metabolites (AUC 0.49), whereas the non-HLA genetic risk score AUC was 0.56 and the HLA risk group AUC was 0.78. CONCLUSIONS: In this large study, we found no support of a predictive role of cord blood concentrations of selected bile acids and other small polar metabolites in the development of type 1 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tapia G, Suvitaival T, Ahonen L, et al. Prediction of Type 1 Diabetes at Birth: Cord Blood Metabolites vs Genetic Risk Score in the Norwegian Mother, Father, and Child Cohort. J Clin Endocrinol Metab. 2021. PMID: 34086903. doi:10.1210/clinem/dgab400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。